Company
Rein Therapeutics
Rein Therapeutics has 1 drug tracked on RxWires: 1 in Phase 2.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| LTI-03 | Phase 2 | Idiopathic Pulmonary Fibrosis (IPF) |
Latest
No recent events.
Follow Rein Therapeutics on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.